type here...

CATEGORIES

Treatments

LATEST

123Page 1 of 3

TRENDING

EDITORS CHOICE

Walgreens Launches Clinical Trial Business to Address Industrywide Access and Diversity Challenges and Redefine Patient Experience

Medika Life -
Walgreens today announced the launch of its clinical trial business to redefine the patient experience and increase access and retention in sponsor-led drug development research.

India: The Growing Focal Point for Health Innovation

Gil Bashe, Medika Life Editor -
India is no longer simply a market to watch. It is a nation shaping the future of global health innovation, a destination for investment,...

Genome Editing and Cellular Therapies Show Promise for Treating Blood Disorders, Cancers

Medika Life -
Three studies report promising results in the use of cutting-edge genome editing and cellular therapies for hard-to-treat blood disorders and cancers.

Is mRNA Technology the New Penicillin?

Robert Turner, Founding Editor -
mRNA medicines are sets of instructions and these instructions direct cells in the body to make proteins to prevent or fight disease. The m stands for messenger and RNA is ribonucleic acid, a part of our DNA

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories